This was the ADR's third consecutive day of losses.

AstraZeneca PLC closed 20.36% short of its 52-week high of £133.88, which the company achieved on September 3rd.

Astrazeneca (AZN) closed the most recent trading day at $73.55, moving -1.17% from the previous trading session. The stock's ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

(Alliance News) - AstraZeneca PLC on Friday reported an AI-focused collaboration with Shijiazhuang City, China-based CSPC Pharmaceutical Group Ltd, boosting its existing presence in the country.

Understand every aspect of the global economy – and know how to make your next move.

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

The shares of the prominent pharmaceutical company gained up to 14 percent in today’s trading session after the company’s net profits and revenue increased by 87 percent QoQ and 25 percent YoY, ...